Biochemistry · 2008 · 324 citations · 17 references
MedicineCell BiologyPharmacologyBiological Transport PhenomenaCellular PharmacologyIntracellular TransportCellular Drug UptakeCellular UptakeTransport Across Biological MembranesTransport In CellsCell InternalizationCellular Internalization PathwaysDrug Transport Across MembranesPassive Cellular EntryPassive DiffusionPassive Ion Diffusion
Transition metal complexes provide a promising avenue for the design of therapeutic and diagnostic agents, but the limited understanding of their cellular uptake is a roadblock to their effective application. Here, we examine the mechanism of cellular entry of a luminescent ruthenium(II) polypyridyl complex, Ru(DIP) 2dppz (2+) (where DIP = 4,7-diphenyl-1,10-phenanthroline and dppz = dipyridophenazine), into HeLa cells, with the extent of uptake measured by flow cytometry. No diminution of cellular uptake is observed under metabolic inhibition with deoxyglucose and oligomycin, indicating an energy-independent mode of entry. The presence of organic cation transporter inhibitors also does not significantly alter uptake. However, the cellular internalization of Ru(DIP) 2dppz (2+) is sensitive to the membrane potential. Uptake decreases when cells are depolarized with high potassium buffer and increases when cells are hyperpolarized with valinomycin. These results support passive diffusion of Ru(DIP) 2dppz (2+) into the cell.
17
A molecular light switch for DNA: Ru(bpy)2(dppz)2+
Alan E. Friedman, J.‐C. Chambron, Jean Pierre Sauvage et al. · Journal of the American Chemical Society · 1990 · 1.4K citations
Ruthenium metallopharmaceuticals
Michael J. Clarke · Coordination Chemistry Reviews · 2003 · 675 citations
Jasmine Walker · Biochemical Education · 1997 · 664 citations